Understanding how to reduce harmful immune responses in T cells
A mechanism to minimize auto-reactivity in the tissue-resident memory T cell pool
This study is looking at how certain immune cells can sometimes turn against the body and cause autoimmune diseases, and it's for anyone interested in understanding how we might improve treatments for these conditions by learning how to keep the immune system balanced.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11085965 on NIH RePORTER |
What this research studies
This research investigates how certain T cells, which are crucial for immune responses, can become harmful and attack the body's own tissues. By studying the development of these T cells in mice, the researchers aim to identify mechanisms that prevent these cells from causing autoimmune diseases. The approach involves examining how TGF-b, a signaling molecule, influences T cell behavior and helps maintain a balance between effective immunity and autoimmunity. If successful, this research could lead to new strategies for treating autoimmune conditions by enhancing the body's ability to regulate its immune responses.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with autoimmune diseases or those at risk of developing such conditions.
Not a fit: Patients with non-autoimmune conditions or those whose immune responses are not related to T cell activity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide new insights into preventing or treating autoimmune diseases, improving patient outcomes.
How similar studies have performed: Previous research has shown promise in understanding T cell regulation and its implications for autoimmune diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Mempel, Thorsten Roman — Massachusetts General Hospital
- Study coordinator: Mempel, Thorsten Roman
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.